Local cerebral blood volume (CBV) has been measured previously with inhaled llCO and positron emission tomography (PET). The model used assumes that equilibrium in tracer concentration has occurred be tween arterial and systemic venous blood before the PET measurement is made. To verify that this model may be used with the much shorter half-lived CISO, we have si multaneously measured arterial and venous blood radio activity following CISO inhalation. Equilibrium occurred 95 ± 39 s after inhalation (n = 7). If the PET measure-
The in vivo measurement of regional cerebral blood volume (rCBV) with positron emission to mography (PET) is useful for two reasons. First, assessment of rCBV in conjunction with regional CBP (rCBF) is important to fully assess cerebral hemodynamics . Second, an independent rCBV measurement must be performed to correct for intravascular ISO ac tivity when the regional CMROz (rCMR02) is mea sured with PET (Lammertsma et ai., 1983; Mintun et ai., 1984) .
Estimation of rCBV requires the administration of a labeled tracer compound that remains limited to the intravascular space of the brain during the PET study. The first tomographic measurement of rCBV reported fulfilled this requirement with 99mTc-labeled red blood cells (Kuhl et ai., 1975) . An alternative approach is to use radiolabeled carbon ment is commenced prior to arteriovenous equilibrium, significant errors occur in calculated CBY. These data in dicate that CISO may be used as a tracer for CBV mea surement provided that emission data collection com mences at � 120 s after inhalation. Strict quality control measures must be maintained to minimize the contamina tion of administered CISO with ISO-labeled CO2, Key Words: Cerebral blood volume-IsO-labeled carbon monoxide-Positron emission tomography. monoxide, which, when inhaled in tracer quan tities, becomes tightly bound to hemoglobin in vivo forming carboxyhemoglobin, hence selectively la beling the red cell mass and fulfilling this require ment. In the past we have performed this measure ment by having the subject inhale "C-Iabeled carbon monoxide (t1/2 = 20.3 min) as first described by Grubb et ai. (1978) . However, in patients under going three separate physiologic measurements (i.e., rCMR02, rCBF, and rCBV) , each requiring the administration of a different labeled compound, we felt it desirable to investigate the use of ISO-la beled carbon monoxide (t'l2 = 2.07 min) for three very practical reasons. First, the use of ISO rather than "c reduces the radiation dose to the patient (Kearfott, 1982) . Second, our measurements could be completed more rapidly and accurately because prolonged, residual, in vivo background activity from ISO-labeled carbon monoxide is almost non existent, whereas it is appreciable after the admin istration of "C-Iabeled carbon monoxide. Finally, our technique for the measurement of rCBF (Her scovitch et ai., 1983; Raichle et ai., 1983) and rCMR02 (Mintun et ai., 1984) involves the adminis tration of ISO-labeled compounds (H2150 and 0150, respectively). Thus, the use of a ISO-labeled com pound rather than a "C-compound for CBV mea-surement simplifies cyclotron operation by elimi nating the need to change targets during a patient run.
The validity of the technique depends on the ac curacy with which 150-labeled carbon monoxide may be used as a tracer of red cell mass. The model used (Grubb et at., 1978) requires that tracer con centration be at equilibrium in both brain and pe ripheral circulation before the measurement is made. The major problem encountered in switching from IIC-Iabeled to 150-labeled carbon monoxide for the measurement of rCBV with PET is to deter mine the appropriate time to scan the patient, i.e., a time late enough that equilibrium has occurred, but early enough that excessive physical decay of 150 has not taken place. The present study was under taken to determine whether tracer equilibration occurs quickly enough to use 150-labeled carbon monoxide for routine rCBV measurements. We found that equilibrium is almost complete within one half-life of 150 and conclude from this that CI50 is practical for routine use. We also call atten tion to the importance of maintaining strict quality control measures to ensure the radiochemical pu rity of the administered CI50.
METHODS
rCBV was measured in seven subjects randomly se lected from among a group of patients undergoing PET studies (i.e., measurements of rCBV, rCBF, and rCMR02) at Washington University Medical Center. For the measurement of rCBV, each subject's blood was la beled in vivo with [1501carboxyhemoglobin by having the subject inhale air containing 50-100 mCi of high specific activity 150-labeled carbon monoxide in three or four breaths. Emission scan data collection commenced � 15-20 s after inhalation, at which time the counting rate from the head was at near maximum levels. A series of five sequential 60-s scans was performed over the next 300 s.
Emission tomography was performed with the PETT VI system for which design and performance characteristics have been discussed elsewhere (Yamamoto et aI., 1982) . Data are recorded si multaneously from seven transverse sections with a center-to-center separation of 14.4 mm. The low-resolu tion mode was utilized giving a transverse resolution of 11.7 mm full width at half-maximum (FWHM) in the center of the field of view and an axial resolution of 13.9 mm FWHM at the center.
Each subject had a radial artery catheter inserted per cutaneously under local anesthesia and an intravenous catheter inserted in the opposite arm. The head was posi tioned with the aid of a vertical laser line projected on the head such that the center of the lowest section corre sponded to the subject's orbitomeatal line. A molded plastic face mask prevented significant head movement during the scan (Ter-Pogossian et aI., 1982) .
Sequential samples of both arterial and venous blood were drawn approximately every 5 s via the arterial and venous catheters. Blood sampling started immediately following isotope administration and continued until the completion of the emission scan. Each blood sample was weighed and counted in a well counter to determine the 150 activity (cps/g blood) and this activity was corrected for the physical decay of 150 from the time administration of 150-labeled carbon monoxide to the subject com menced to the time activity was measured. Curves of the decay-corrected blood activity as a function of time were constructed for both arterial and venous blood.
Calibration of the tomograph to obtain actual regional isotope concentration in the brain from the reconstructed image (cps/ml tissue) was performed by imaging a phantom divided into six wedge-shaped chambers. The chambers were filled with varying concentrations of llC_ labeled bicarbonate. Aliquots from each chamber were counted in the same well counter used for measurement of blood activity and the observed counting rate was decay corrected to the time scanning of the phantom commenced. From these data the total number of counts presented to the tomograph during the length of the scan was obtained as described elsewhere (Raichle et aI., 1983) . A regression equation comparing the relative scan data and the directly measured activity in the phantom was obtained after reconstruction of the phantom image. This relationship permitted the actual local isotope con centrations to be obtained from each patient's scan. Pa tient PET scan data were corrected for the physical decay of 150 that occurs during the study (defined as the time from tracer administration to scan completion) as described in detail elsewhere (Raichle et aI., 1983; Her scovitch et aI., 1984; Mintun et aI., 1984) .
rCBV (mIIlOO g tissue) was calculated using the fol lowing equation:
where PET is the accumulated counts per unit volume from the beginning (t l ) to the end (t2) of the scan; Cbl is the blood activity integrated over the time of the scan, R is the ratio of cerebral small-vessel hematocrit to large vessel hematocrit, dbl is the density of blood (g/m!), and dt is the density of cerebral tissue (g/ml). A value of 0.85 was used for the ratio of cerebral small-vessel to large vessel hematocrit (Grubb et aI., 1973) , and a value of 1.05 giml was used for the density of both blood and cerebral tissue.
rCBV was calculated both with the arterial blood curve and with the venous blood curve for each of the 60-s pe riods during which emission scan data were collected. This calculation was performed for each pixel in each re constructed image. A color-coded map with each color representing the quantitative rCBV value (mIIIOO g) was displayed. Since the patient's head did not change posi tion between scans, it was possible to select a region of interest in one scan, store the location in computer memory, and display the same region of interest in the same anatomical location on the other scans done on that patient. The region of interest used for this study was 13.5 x 13.5 mm, selected from frontal cortex identified on the rCBF scan. The identical region of interest was then placed on the rCBV studies to ensure that its place ment was entirely within cerebral tissue (cortex and sub cortical white matter).
In a different group of patients, the administered CI50 was assessed for the presence of COl50 contamination by gas chromatography. Calculation of rCBV was performed from a 5-min emission scan starting after equilibrium was attained and results obtained in the absence of significant COl50 contamination were compared with those ob tained in patients who inhaled CI50 contaminated with C0 150.
These studies were approved by the Human Studies Committee and the Radioactive Drug Research Com mittee (FDA) of the Washington University School of Medicine. Informed consent was obtained from each pa tient prior to the study.
RESULTS
Arterial and venous blood curves suitable for analysis were obtained in each of seven patients. Equilibrium, i.e., equal arterial and venous 150 ac tivity, was achieved from 48 to 155 s after inhala tion. The mean time lapse (± SD) from the begin ning of inhalation until equilibrium was 95 ± 39 s. A typical pair of blood curves is illustrated in Fig. 1 along with the sequential calculations of rCBV in that patient.
Sequential scans in 60-s time frames were suit able for analysis in five patients. Te chnical factors prevented the performance of sequential scans in the other two patients. The total 150 activity as well as the regional cortical activity in each slice de creased on sequential studies at the rate predicted by the 150 decay constant. The cortical rCBV cal culated from the first 60-s frame of emission data (before equilibrium was achieved) using the arterial blood curve differed markedly from that calculated from the same emission data with the venous blood curve. Use of the venous curve in this frame pro- curves with sequential calculations of regional cerebral blood volume (rCBV) based on these curves and on the se quential 60-s emission scans in a typical patient (no. P197 in Table 1 ). Blood curves demonstrate that equilibrium occurs -120 s after inhalation in this patient. Calculated rCBV is constant after this point. duced a calculated rCBV that was up to double that calculated using the arterial curve. In the second 60-s frame, the rCBV (venous curve) had decreased while the rCBV (arterial curve) had increased. In each of the last three 60-s frames, cortical CBV was relatively constant and was similar with both arte rial and venous blood curves (because the curves were essentially identical by this point). There was an apparent slight overestimation of rCBV with venous blood sampling with measurements per formed after 120 s. Subject data are summarized in Ta ble 1. Figure 2 illustrates a typical CBV scan per formed after inhalation of C150.
Assessment of radiochemical purity of the in haled tracer showed it to contain <0.1% COl50 in most patients. Contamination with COl50 was seen to produce an rCBV image strikingly similar to an rCBF image where there is no sharp delineation be tween cerebral tissue and vascular spaces. The ef fect of 3% COl50 contamination is illustrated in Fig. 3 .
DISCUSSION
An assumption inherent in the model for the mea surement of rCBV is that the entire intravascular volume is uniformly labeled; i.e., both arterial and venous blood have the same tracer concentration. CBV has been measured previously with PET using Ilca (Grubb et aI., 1978; Phelps et aI., 1979) . In this situation, the intravascular tracer [IIC]car boxyhemoglobin has a relatively long physical half life and equilibrium between arterial and venous concentration has been assumed by allowing 4-7 min for equilibration before commencing emission data collection (Grubb et aI., 1978; Phelps et aI., 1979) . However, when CI50 is used, the short half life dictates the necessity of commencing the emis sion scan as soon as possible after inhalation. Our data show that equilibration of 150 activity between peripheral arterial and venous blood is almost com plete within 2 min following inhalation in most sub jects. It is probable that equilibrium between the brain and peripheral circulation has also occurred by this time. The intersubject variability demon strated in our data likely reflects variation in the amount and rate of CI50 inhalation as well as in physiological factors such as cardiac output and circulation time.
The calculation of local CBV based on emission data collected in sequential 60-s time frames shows the calculated CBV to be constant during later time frames regardless of the use of the arterial or the venous curve. As illustrated in Fig. 1, this is not the case at early times. During the initial 60 s, use of rCBV, regional cerebral blood volume.
a Time from 050 inhalation to arteriovenous equilibrium.
b Time frames measured in seconds from the beginning of emission data collection (-20 s after inhalation).
the venous curve results in an artifactually elevated CBV that decreases to a constant value in subse quent frames. Use of the arterial curve in the initial time frame produces an artifactually low CBV that increases to a constant value in subsequent frames.
Our data suggest that the early disparity is related directly to the difference between these two blood curves. At early times integrated arterial activity is much higher than integrated venous activity. The appearance of a constant calculated CBV coincides FIG. 2. Typical quantitative measurement of regional cerebral blood volume (rCBV) in normal adult male subject using a bolus inhalation of C150. Data were collected over 300 s, starting 120 s after isotope inhalation. The quantitative gray scale (m1l100 g) is set to the same maximum (10.0 mll100 g) for each slice. Specific regions have been selected in each slice to illustrate rCBV variations. The mean CBV and the standard deviation of the 25 pixels in each region are listed below each slice. These regions were selected from cerebral cortex, white matter, and cerebellum identified on CBF studies. Note the areas of high blood volume corresponding to venous sinuses as well as areas of high blood volume outside the cerebral cortex corresponding to skull and scalp.
FIG. 3. Top: Positron emission tomography (PET) measurements of regional cerebral blood volume (rCBV) with C15Q that contained no CQ15Q when assayed by gas chromatography (left) and corresponding PET measurement of regional CBF (rCBF) after bolus intravenous injection of H215Q (right). Bottom: PET measurement of rCBV using C15Q contaminated with 3% CQ15Q (left). Note the loss of sharp definition between the sagittal sinus posteriorly and the brain tissue and the similarity to the corresponding H215Q rCBF scan (right).
with the approach to arteriovenous equilibrium, al though our data suggest that tracer equilibration may still be incomplete at later times since there is a slight overestimation of rCBV at these times if the venous blood curve is used.
These results indicate that the accurate calcula tion of CBV requires a delay in emission data col lection of � 120 s from the time of inhalation. By this time, only minimal error will be introduced if equilibration is not quite complete. This implies that if Cl50 is used, sufficient activity must be in haled to permit the collection of an adequate number of counts after in vivo physical decay ap proaching one half-life. We have found that the rou tine administration of 60-100 mCi of el50 results in a reasonable counting rate under these condi tions.
A second assumption in the model is that local tissue hematocrit may be estimated if large-vessel hematocrit is measured. We have used a value of 0.85 for the ratio of tissue hematocrit to large vessel hematocrit (Grubb et aI., 1973) . The use of this arbitrary value may introduce some errors into calculated CBV if there is a regional variation in local tissue hematocrit as suggested by Sakai et ai. (1985) or if it changes with cerebral pathology (Ro senblum, 1972) . This error may be circumvented by determining local tissue hematocrit directly by se quential measurement of regional plasma volume and red cell volume (Lammertsma et aI., 1984; Sakai et aI., 1985) .
Strict quality control measures are necessary to ensure the radiochemical purity of administered C150. During synthesis, a variable amount of [150]carbon dioxide (COI50) is produced, and un less this is removed, large errors in the measure ment of eBV can result. COl50 absorbed through the lungs is converted to H2l50 by carbonic anhy drase in red blood cells and distributes in the total body water. At equilibrium the volume of distribu tion of H2l50 in the brain will be 91 ml/l00 g (Her scovitch and as compared with only 4 ml/100 g for CO-labeled red cells (Grubb et aI., 1978; Phelps et aI., 1979) . Thus, the relative contri bution of HPO to radioactivity measured in a re gion of brain will be >20 times greater than its rela tive concentration in the blood. If only 0.5% of total blood radioactivity is due to H2l50, CBV will be overestimated by � 10%. This problem is further compounded by the fact that eOl5o diffuses across the alveolar capillary membrane 10 times faster than does el50 (Matthews et aI., 1966) . As a result, COl50 will be preferentially absorbed and concen trated in the blood when a mixture of the two gases is inspired under nonequilibrium conditions, such as brief inhalation.
The effect of C0150-H2150 contamination can be seen on the PET image as both an increase in the measured CBV and a loss of definition between the major vascular structures and the surrounding brain tissue (Fig. 3) . In practice, the magnitude of this contamination can easily be estimated by centri fuging a blood sample and determining the fraction of total blood radioactivity that is present in the plasma. In the absence of hemolysis, the amount of C150 in plasma is <0.2% and any radioactivity in excess of this may be attributed to H2150.
Accurate rCBV quantitation with PET is of im portance for several reasons. Measurement of CBV in conjunction with CBF and CMR02 has been shown to be of value in the in vivo assessment of cerebral circulation Gibbs et al., 1984; Powers et aI., 1984 Powers et aI., , 1985 . In particular, CBV data provide insights into the de gree of the autoregulatory response in patients with impaired cerebral perfusion pressure secondary to extraparenchymal cerebral vascular disorders . In addition, accurate measurement of local CMR02 with PET requires a correction for unmetabolized 1502 in the vascular compartment (Lammert sma and Jones, 1983; Mintun et aI., 1984) , which in turn requires the measurement of local CBY. This mea surement is simplified with the use of inhaled C150 as a vascular tracer, provided care is taken to en sure that equilibrium is attained prior to com mencement of scanning and to ensure adequate ra diochemical purity of the tracer.
